CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Impax Laboratories, Inc. Company Snapshot
Impax Laboratories, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Impax Laboratories with three other companies in this sector in the United States: Biomarin Pharmaceutical Inc (2015 sales of $889.90 million of which 34% was Naglazyme), Horizon Pharma PLC ($757.04 million of which 100% was Food & Drug Administration), and Medivation, Inc. ($943.26 million of which 100% was Medical Technologies).

Sales Analysis. Impax Laboratories reported sales of $860.47 million for the year ending December of 2015. This represents an increase of 44.4% versus 2014, when the company's sales were $596.05 million. The sales level in 2015 was fairly close to the level five years ago: in 2010, Impax Laboratories had sales of $879.51 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Impax Laboratories, Inc.
  Stock Performance Chart for Impax Laboratories, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/23/2016): 26.49
(Figures in U.S. Dollars)
1 Week 1.3%   13 Weeks 10.7%  
4 Weeks -9.5%   52 Weeks -34.6%  
 
Impax Laboratories, Inc. Key Data:
  Ticker: IPXL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 860,469,000
(Year Ending Jan 2016).
Employees: 1,290
  Currency: U.S. Dollars Market Cap: 1,956,533,466
  Fiscal Yr Ends: December Shares Outstanding: 73,859,323
  Share Type: Common Closely Held Shares: 4,321,844
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.